Organization | Field Name | ID | Required |
|---|---|---|---|
KCR | AJCC TNM Post Therapy Path (yp) T (AJCC8TNMPostTxT) | 33162 | Yes |
AJCC | AJCC TNM Post Therapy Path (yp) T | Yes |
Field length: 15
This field will be used for cases 01/01/2018 and forward.
Description
Evaluates the primary tumor (T) and reflects the tumor size and/or extension of the tumor known following the completion of neoadjuvant therapy (satisfying the definition for that disease site) and planned post-neoadjuvant therapy surgical resection.
Rationale
CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results.
Codes (in addition to those published in the AJCC 8th edition Cancer Staging Manual)
| Code | Description |
|---|---|
| 88 | Not applicable, no code assigned for this case in the current AJCC Staging Manual. |
| Blank | This field is left blank if no information at all is available to code this item. |
Note: See the AJCC 8th edition Cancer Staging Manual, current edition for site-specific categories for the TNM categories and stage groups. See the CURRENT STORE manual for specifications for codes and data entry rules.
Overview
Content Tools
Activity